Golden Eagle

Director focused on sourcing, managing and closing equity and debt transactions. Brings over 18 years of capital markets experience with expertise in due diligence and analytics across alternative investments. Previously worked at Somerset Capital, AR2 Capital, Alpha Strategies, and held fixed income trading roles at Continental Investor Services and First Southwest Company.

Founder of Golden Eagle Partners in 2012, initially focused on life science advisory before transitioning to cannabis sector. Brings 15+ years of biotechnology operational experience spanning R&D, manufacturing, and business development roles at companies acquired by major firms including Amgen, Baxter, and Thermo Fisher. Previously served at investment banking firms advising on over $500 million in transactions.

Trained pharmacologist with Ph.D. from University College London and decades of pharmaceutical R&D experience at Wellcome Research Laboratories and Roche Biosciences. Led molecular pharmacology research on G-protein coupled receptors and contributed to development of marketed drug Zomig for migraine treatment. Founded HatchBox Bioconsulting in 2017 to support early-stage life science innovation.

Ph.D. biochemist and current Chief Research Officer at Panacea Life Sciences, which he grew from a virtual startup to a GMP-certified vertically integrated cannabinoid company with 30+ staff. Brings extensive biotechnology and pharmaceutical research leadership spanning Amgen, Zymogenetics, and other major firms, with expertise in drug discovery and development.

Advisor to Golden Eagle Partners and currently Chief Research Officer at Panacea Life Sciences. Joined Panacea in 2017 as President and CEO, leading its growth from 4 employees to a GMP-certified vertically integrated cannabinoid company with 30+ staff. Holds Ph.D. in biochemistry and has led research teams at major pharmaceutical companies including Amgen and Zymogenetics, with 11 patents to his name.

Independent consultant specializing in regulatory policy and governmental affairs. Retired from Colorado Department of Revenue after 25+ years, including 5 years as Senior Director of Enforcement overseeing multiple divisions. Recognized expert in marijuana regulatory policy implementation, having been instrumental in establishing Colorado's retail marijuana framework and advising on policy evolution in multiple states.